LAG3 and cancer: LAG-3 is an inhibitory receptor that limits the activation and proliferation of the LAG-3-expressing cells (18–20) and has been identified as an “immune checkpoint” molecule that can be targeted by antibodies to enhance anti-cancer immune responses (reviewed in (21)).